Walsh Angela has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 82500 shares of Dogwood Therapeutics, Inc. ($DWTX) on March 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Dogwood Therapeutics, Inc. | $DWTX | Walsh Angela | Chief Financial Officer | A | Stock Option (right to buy) | 82500 | $0.00 | 82,500.0000 | 1,919,433 | 9999.99% | 4.30% |
| Dec. 4, 2025 | Dogwood Therapeutics, Inc. | $DWTX | Walsh Angela | Chief Financial Officer | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 1,919,433 | 9999.99% | 7.81% |
| June 27, 2025 | Dogwood Therapeutics, Inc. | $DWTX | Walsh Angela | Chief Financial Officer | A | Stock Option (right to buy) | 12075 | $0.00 | 12,075.0000 | 1,441,535 | 9999.99% | 0.84% |
| Feb. 26, 2024 | Dogwood Therapeutics, Inc. | $DWTX | Walsh Angela | SVP OF FINANCE | A | Stock Option (right to buy) | 63618 | $0.00 | 63,618.0000 | 751,071 | 9999.99% | 8.47% |